In 2018 I was appointed full professor of Pharmaceutical Biotechnology & Delivery at the Pharmaceutics division of the department of Pharmaceutical Sciences at Utrecht University, The Netherlands. In this contribution to the Orations – New Horizons of the Journal of Controlled Release I will introduce my research group (see also www.uu.nl/pharmaceutics) and will highlight my current and future research projects. In coming years the focus of my research will be on the administration of biotherapeutics, aiming to control their fate from the site of injection to the site of action. I will discuss issues related to formulation of biotherapeutics into nanomedicines (NMs), intracellular delivery of nucleic acids as well as protein therapeutics, and targeted delivery of biotherapeutics beyond the liver. In addition, I will provide a forward view on how current developments in the drug delivery and gene therapy field may result in sustainable and cost-effective dosing regimens for biotherapeutics. “The Nanomedicine Universe” according to Enrico Mastrobattista. Display omitted •Highlights of research on intracellular delivery of protein and nucleic acid therapeutics using nanomedicine•Ideas on how to deliver biotherapeutics to tissues and organs other than liver and spleen•Future insights into sustainable dosing of biotherapeutics via genetic modification of endogenous cells•Importance of monitoring the effects of post-production handling of biopharmaceuticals on stability and potency